The efficacy and safety of 10 mg vortioxetine in the treatment of major depressive disorder: a meta-analysis of randomized controlled trials
Guangjian Li, Xu Wang, Dihui Ma Department of Neurology and Neuroscience Center, First Hospital of Jilin University, Changchun, People’s Republic of China Background: Vortioxetine is an investigational multimodal antidepressant. We conducted this meta-analysis to assess the efficacy...
Saved in:
Main Authors: | Li G, Wang X, Ma D |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2016-02-01
|
Series: | Neuropsychiatric Disease and Treatment |
Subjects: | |
Online Access: | https://www.dovepress.com/the-efficacy-and-safety-of-10-mg-vortioxetine-in-the-treatment-of-majo-peer-reviewed-fulltext-article-NDT |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The efficacy and safety of multiple doses of vortioxetine for generalized anxiety disorder: a meta-analysis
by: Fu J, et al.
Published: (2016-04-01) -
Efficiency and safety of Vortioxetine in the treatment of depressive disorders in cardiac patients
by: N. V. Filippova, et al.
Published: (2023-06-01) -
Optimizing the diagnosis and treatment of depression in primary care: the emerging role of vortioxetine treatment
by: José Ángel Alcalá, et al.
Published: (2025-07-01) -
Vortioxetine for depression treatment in hospital setting: experience from a single psychiatric hospital
by: O. V. Limankin, et al.
Published: (2020-10-01) -
The effectiveness of vortioxetine in patients with depression in real clinical practice
by: N. N. Petrova
Published: (2022-10-01)